Supplemental therapy to battle against post-COVID-19 difficulties

supplemental-therapy-to-battle-against-post-covid-19-difficulties
Image Credit: shutterstock.com

ImmunoSEB + ProbioSEB CSC3 is confirmed to be beneficial for post-resolution of mild to moderate COVID-19 patients

ImmunoSEB + ProbioSEB CSC3 as supplemental therapy has been confirmed to be beneficial in mild to moderate COVID-19 patients and showed overall clinical improvement in WHO 7-point ordinal scale. A randomised, open-label, 2 Arm, prospective study was investigated for the safety and efficacy of the health supplements. Dr Neha Shah, Dr Rohit Parate and Dr Abhay Vispute published their findings on a new COVID-19 clinical trial in the Medical Journal of Advances in Clinical Toxicology

 

The researchers investigated to evaluate the effect on the primary endpoint of the experimental regimen through pairwise comparisons of the testing regimen ImmunoSEB + ProbioSEB CSC3 with a standard-of-care control arm and under a sequential design. The clinical trials were carried out on 60 patients in two centres, SRV Hospital, Mumbai and Chirayu Medical College, and Hospital, Bhopal.

 

Recent clinical studies indicate that this supplement supports the recovery of covid patients. The length of time to experience the benefits of the supplement varies by individual. Some people notice a difference within days. For others, it’s a week or ten days. For long-term benefits, it’s essential to take the immunity bundle consistently over several months. Regular, consistent use of the supplement will provide the best results. However, missed doses of the supplement do not cause any harm. Consume the following amount as per your daily regime.

 

According to Management of Post COVID-19 Fatigue using Systemic Enzymes and Probiotics- Case Series covered by the Medical Journal of Clinical Trials and Case Studies, “The present cases support the use of a 14 days supplementation of a combination of ImmunoSEB + ProbioSEB CSC3 to improve COVID-19 induced fatigue in patients post-resolution of mild to moderate COVID-19 disease. However, there is a need for large-scale, placebo-controlled prospective studies to evaluate this effect further.”

 

“Throughout this pandemic situation, we tried hard to fix this unsolvable puzzle of saving lives post-covid with natural solutions that can help people who are grieving. Enzymes and probiotics are robust mechanisms for stamina and vitality, and the medicine and investigation confirm it.” conveys Dr Shah, Program Coordinator, VA Long Beach Healthcare Center, California.

Read Previous

JM Financial Private Equity invests Rs 350 M in Walko Food Company

Read Next

PAU signs pact for brewed fruit vinegar technology

Leave a Reply